Found: 4
Select item for more details and to access through your institution.
p57Kip2 is a downstream effector of BCR–ABL kinase inhibitors in chronic myelogenous leukemia cells.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 1, p. 10, doi. 10.1093/carcin/bgq211
- By:
- Publication type:
- Article
Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
- Published in:
- Carcinogenesis, 2008, v. 29, n. 3, p. 560
- By:
- Publication type:
- Article
EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34<sup>+</sup> Cell Differentiation and Increases Circulating Endothelial Precursors.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012015
- By:
- Publication type:
- Article
Antioxidants induce different phenotypes by a distinct modulation of signal transduction
- Published in:
- FEBS Letters, 2002, v. 532, n. 3, p. 289, doi. 10.1016/S0014-5793(02)03683-9
- By:
- Publication type:
- Article